Koch Eye Associates Llp | |
20 Hampton Way, Bldg 1a, Wakefield, RI 02879-2553 | |
(401) 783-7009 | |
(401) 789-3909 |
Full Name | Koch Eye Associates Llp |
---|---|
Type | Facility |
Speciality | Eyewear Supplier |
Location | 20 Hampton Way, Wakefield, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093266512 | NPI | - | NPPES |
CC8793 | Other | RAILROAD MEDICARE |
Mailing Address | Practice Location Address |
---|---|
Koch Eye Associates Llp 51 State Rd, Dartmouth, MA 02747-3319 Ph: (774) 320-3040 | Koch Eye Associates Llp 20 Hampton Way, Bldg 1a, Wakefield, RI 02879-2553 Ph: (401) 783-7009 |
News Archive
IncellDx, Inc., a sponsor at the International HPV meeting this week in Montreal, Canada, announces that two presentations at the meeting demonstrated that IncellDx's HPV OncoTect E6/E7 mRNA kit greatly increases specificity compared to other HPV tests and was successfully used in a large clinical trial in women under 30 years of age.
The PBS NewsHour's "The Rundown" blog features an interview with journalist Jon Cohen, in which he discusses the possibility of an "AIDS-free generation," recent reports from UNAIDS and the Centers for Disease Control and Prevention, AIDS funding, HIV vaccine research, and World AIDS Day.
A unique health economics assessment of copper's role in preventing healthcare-associated infections is being presented this week at the WHO's International Conference on Prevention and Infection Control in Geneva, demonstrating rapid payback on the capital investment.
Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening, lead optimization, and antibody drug development, announced today that the companies have formed a strategic partnership to offer a complete platform for producing human antibody therapeutics.
Ramadan fasting can be safe for patients with heart failure, according to research presented today at the 29th Annual Conference of the Saudi Heart Association, held 1 to 3 March in Riyadh, Saudi Arabia.
› Verified 5 days ago